- Home
- DYAI vs KZR Comparison
DYAI vs KZR Comparison
Compare DYAI & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYAI
- KZR
- Stock Information
- Founded
- DYAI 1979
- KZR 2015
- Country
- DYAI United States
- KZR United States
- Employees
- DYAI N/A
- KZR N/A
- Industry
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- DYAI Health Care
- KZR Health Care
- Exchange
- DYAI Nasdaq
- KZR Nasdaq
- Market Cap
- DYAI 30.2M
- KZR 29.7M
- IPO Year
- DYAI 2004
- KZR 2018
- Fundamental
- Price
- DYAI $1.13
- KZR $6.25
- Analyst Decision
- DYAI Strong Buy
- KZR Hold
- Analyst Count
- DYAI 2
- KZR 4
- Target Price
- DYAI $4.50
- KZR $6.00
- AVG Volume (30 Days)
- DYAI 105.9K
- KZR 459.3K
- Earning Date
- DYAI 11-10-2025
- KZR 11-11-2025
- Dividend Yield
- DYAI N/A
- KZR N/A
- EPS Growth
- DYAI N/A
- KZR N/A
- EPS
- DYAI N/A
- KZR N/A
- Revenue
- DYAI $4,135,078.00
- KZR N/A
- Revenue This Year
- DYAI $34.23
- KZR N/A
- Revenue Next Year
- DYAI $19.57
- KZR N/A
- P/E Ratio
- DYAI N/A
- KZR N/A
- Revenue Growth
- DYAI 129.20
- KZR N/A
- 52 Week Low
- DYAI $0.71
- KZR $3.53
- 52 Week High
- DYAI $2.20
- KZR $8.45
- Technical
- Relative Strength Index (RSI)
- DYAI 52.71
- KZR 78.72
- Support Level
- DYAI $1.10
- KZR $6.06
- Resistance Level
- DYAI $1.27
- KZR $6.28
- Average True Range (ATR)
- DYAI 0.11
- KZR 0.27
- MACD
- DYAI 0.00
- KZR 0.15
- Stochastic Oscillator
- DYAI 44.84
- KZR 93.48
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.